230 related articles for article (PubMed ID: 31503493)
1. Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs.
Dash RP; Tichý T; Veeravalli V; Lam J; Alt J; Wu Y; Tenora L; Majer P; Slusher BS; Rais R
Mol Pharm; 2019 Oct; 16(10):4292-4301. PubMed ID: 31503493
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Brain Delivery of 2-(Phosphonomethyl)pentanedioic Acid Following Intranasal Administration of Its γ-Substituted Ester Prodrugs.
Nedelcovych M; Dash RP; Tenora L; Zimmermann SC; Gadiano AJ; Garrett C; Alt J; Hollinger KR; Pommier E; Jančařík A; Rojas C; Thomas AG; Wu Y; Wozniak K; Majer P; Slusher BS; Rais R
Mol Pharm; 2017 Oct; 14(10):3248-3257. PubMed ID: 28763226
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC
Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075
[TBL] [Abstract][Full Text] [Related]
4. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.
Krečmerová M; Majer P; Rais R; Slusher BS
Front Chem; 2022; 10():889737. PubMed ID: 35668826
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
[TBL] [Abstract][Full Text] [Related]
6. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.
Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS
PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906
[TBL] [Abstract][Full Text] [Related]
7. N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs.
Zimmermann SC; Tichý T; Vávra J; Dash RP; Slusher CE; Gadiano AJ; Wu Y; Jančařík A; Tenora L; Monincová L; Prchalová E; Riggins GJ; Majer P; Slusher BS; Rais R
J Med Chem; 2018 May; 61(9):3918-3929. PubMed ID: 29648826
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice.
Naesens L; Bischofberger N; Augustijns P; Annaert P; Van den Mooter G; Arimilli MN; Kim CU; De Clercq E
Antimicrob Agents Chemother; 1998 Jul; 42(7):1568-73. PubMed ID: 9660984
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Orally Available Prodrugs of the Glutamate Carboxypeptidase II (GCPII) Inhibitor 2-Phosphonomethylpentanedioic Acid (2-PMPA).
Majer P; Jančařík A; Krečmerová M; Tichý T; Tenora L; Wozniak K; Wu Y; Pommier E; Ferraris D; Rais R; Slusher BS
J Med Chem; 2016 Mar; 59(6):2810-9. PubMed ID: 26930119
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
11. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
12. Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease.
Date AA; Rais R; Babu T; Ortiz J; Kanvinde P; Thomas AG; Zimmermann SC; Gadiano AJ; Halpert G; Slusher BS; Ensign LM
J Control Release; 2017 Oct; 263():132-138. PubMed ID: 28159515
[TBL] [Abstract][Full Text] [Related]
13. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
14. Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes.
Tiffany CW; Cai NS; Rojas C; Slusher BS
Eur J Pharmacol; 2001 Sep; 427(2):91-6. PubMed ID: 11557259
[TBL] [Abstract][Full Text] [Related]
15. Factors limiting the extent of absolute bioavailability of pradefovir in rat.
Xiao Q; Yang W; Wang D; Chen L; Yuan L; Ding Y; Yang J
Xenobiotica; 2016 Oct; 46(10):913-21. PubMed ID: 26846680
[TBL] [Abstract][Full Text] [Related]
16. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
Krise JP; Charman WN; Charman SA; Stella VJ
J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
[TBL] [Abstract][Full Text] [Related]
17. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood.
Eisenberg EJ; He GX; Lee WA
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1091-8. PubMed ID: 11562963
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and bioavailability of the anti-human immunodeficiency virus nucleotide analog 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.
Cundy KC; Sueoka C; Lynch GR; Griffin L; Lee WA; Shaw JP
Antimicrob Agents Chemother; 1998 Mar; 42(3):687-90. PubMed ID: 9517952
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study.
Van Gelder J; Annaert P; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1999 Jul; 16(7):1035-40. PubMed ID: 10450927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]